HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baocun Sun Selected Research

cadherin 5

1/2019S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer.
8/2017VEGFR2 regulates endothelial differentiation of colon cancer cells.
8/2016Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma.
3/2016miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
1/2016Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
8/2015Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin Signaling.
4/2015Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
6/2014Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
9/2007Vasculogenic mimicry: current status and future prospects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baocun Sun Research Topics

Disease

86Neoplasms (Cancer)
12/2021 - 10/2002
39Neoplasm Metastasis (Metastasis)
01/2021 - 03/2004
27Breast Neoplasms (Breast Cancer)
12/2021 - 03/2004
17Melanoma (Melanoma, Malignant)
08/2020 - 10/2002
11Hypoxia (Hypoxemia)
08/2017 - 05/2007
10Carcinoma (Carcinomatosis)
03/2020 - 03/2008
9Hepatocellular Carcinoma (Hepatoma)
01/2019 - 12/2014
9Lymphatic Metastasis
01/2018 - 03/2004
5Colonic Neoplasms (Colon Cancer)
08/2017 - 04/2012
5Triple Negative Breast Neoplasms
01/2017 - 11/2008
4Colorectal Neoplasms (Colorectal Cancer)
12/2017 - 04/2012
4Lung Neoplasms (Lung Cancer)
04/2017 - 05/2014
4Experimental Melanoma
05/2009 - 01/2006
3Adenoma (Adenomas)
04/2019 - 08/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 03/2011
3Ovarian Epithelial Carcinoma
01/2015 - 06/2014
3Sarcoma (Soft Tissue Sarcoma)
10/2014 - 10/2002
3Synovial Sarcoma (Synovioma)
06/2011 - 06/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 03/2012
2Adenocarcinoma of Lung
01/2019 - 01/2018
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2016 - 12/2012
2Rhabdomyosarcoma
09/2015 - 10/2002
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2014 - 02/2013
2Ovarian Neoplasms (Ovarian Cancer)
08/2014 - 06/2014
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
03/2012 - 03/2008
2Osteosarcoma (Osteogenic Sarcoma)
11/2011 - 04/2010
2T-Cell Lymphoma (Lymphoma, T Cell)
05/2011 - 05/2008
2Carcinogenesis
05/2010 - 01/2010
2Necrosis
05/2009 - 11/2008
1Wounds and Injuries (Trauma)
12/2021
1Anaplastic Thyroid Carcinoma
04/2019
1Follicular Adenocarcinoma
04/2019

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
04/2019 - 03/2004
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017 - 10/2006
11Messenger RNA (mRNA)IBA
10/2014 - 03/2004
10VimentinIBA
11/2018 - 11/2008
10Biomarkers (Surrogate Marker)IBA
01/2018 - 03/2008
9cadherin 5IBA
01/2019 - 09/2007
8Small Interfering RNA (siRNA)IBA
08/2020 - 03/2008
8Cadherins (E-Cadherin)IBA
04/2019 - 11/2007
8CateninsIBA
01/2017 - 04/2012
8ParaffinIBA
06/2015 - 10/2002
7Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2014
5MicroRNAs (MicroRNA)IBA
08/2016 - 01/2015
4LigandsIBA
08/2020 - 02/2010
4Matrix Metalloproteinases (MMPs)IBA
12/2017 - 10/2006
4Periodic AcidIBA
09/2015 - 01/2006
4Oxygen (Dioxygen)IBA
09/2014 - 01/2006
4Indicators and Reagents (Reagents)IBA
12/2012 - 06/2006
4Progesterone Receptors (Progesterone Receptor)IBA
03/2012 - 09/2007
4Cyclin D1IBA
06/2011 - 03/2004
3Phosphopyruvate Hydratase (Enolase)IBA
03/2021 - 03/2004
3Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 08/2010
3Biological ProductsIBA
01/2017 - 06/2004
3Epidermal Growth Factor (EGF)IBA
08/2016 - 06/2009
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2015 - 07/2007
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2015 - 03/2009
3CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
07/2014 - 03/2008
3Phenobarbital (Luminal)FDA Link
07/2014 - 12/2011
3Estrogen ReceptorsIBA
03/2012 - 03/2008
3ClusterinIBA
03/2012 - 12/2006
3Formaldehyde (Formol)FDA Link
11/2011 - 12/2006
3DNA (Deoxyribonucleic Acid)IBA
04/2009 - 06/2004
2AntigensIBA
03/2021 - 12/2012
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2020 - 03/2012
2Long Noncoding RNAIBA
10/2018 - 02/2016
2Interleukin-6 (Interleukin 6)IBA
12/2017 - 09/2015
2Conditioned Culture MediaIBA
08/2017 - 10/2016
2ProgesteroneFDA LinkGeneric
04/2017 - 05/2010
2CalciumIBA
01/2016 - 12/2014
2Protein Kinases (Protein Kinase)IBA
01/2016 - 08/2014
2Phosphotransferases (Kinase)IBA
09/2015 - 06/2009
2Matrix Metalloproteinase 13IBA
04/2015 - 03/2008
2Urokinase Plasminogen Activator ReceptorsIBA
04/2015 - 01/2014
2Doxycycline (Periostat)FDA LinkGeneric
12/2014 - 11/2007
2Angiogenesis InhibitorsIBA
09/2014 - 03/2011
2Sunitinib (Sutent)FDA Link
09/2014 - 03/2011
2Caspase 3 (Caspase-3)IBA
07/2014 - 08/2013
2human ERBB2 proteinIBA
01/2013 - 03/2012
2Estrogens (Estrogen)FDA Link
03/2012 - 09/2007
2Chemokine ReceptorsIBA
05/2011 - 02/2010
2TubulinIBA
04/2009 - 11/2008
2Laminin (Merosin)IBA
06/2008 - 09/2007
2GelatinIBA
03/2008 - 11/2007
2SuspensionsIBA
11/2007 - 01/2006
2Fibronectins (Fibronectin)IBA
07/2007 - 03/2004
2Platelet Endothelial Cell Adhesion Molecule-1IBA
01/2006 - 10/2002
1Eukaryotic Initiation Factor-4EIBA
12/2021
1Peptide Initiation Factors (Initiation Factor)IBA
12/2021
1Cell Adhesion MoleculesIBA
12/2021
1Collagen Type I (Type I Collagen)IBA
01/2021
1ThyroglobulinFDA Link
03/2020
1Twist Transcription FactorsIBA
04/2019
1prolinedithiocarbamate (PDTC)IBA
04/2019
1RacivirIBA
04/2019
1antigen CYFRA21.1IBA
01/2019

Therapy/Procedure

19Therapeutics
08/2020 - 07/2007
4Drug Therapy (Chemotherapy)
01/2019 - 12/2006
2Lasers (Laser)
08/2010 - 07/2007
1Replantation
12/2021